{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:11:07Z","timestamp":1793121067469,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Carbapenem-resistant\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      (CRKp) is an urgent global health threat due to its rapid spread and limited treatment options. Ceftazidime\u2013avibactam exhibits broad efficacy against gram-negative bacteria, including CRKp; however, emerging resistance to this agent is increasingly reported. Understanding the prevalence of ceftazidime\u2013avibactam resistance and the underlying carbapenemase genes is critical for optimizing antimicrobial stewardship and guiding clinical management. This study aimed to determine the prevalence of ceftazidime avibactam resistance among CRKp isolates collected from various clinical specimens, and to analyze their associated carbapenemase genes and antibiotic resistance profiles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This cross-sectional study analyzed 312\n                      <jats:italic toggle=\"yes\">K pneumoniae<\/jats:italic>\n                      isolates obtained from various clinical specimens of hospitalized patients at a tertiary care hospital in Turkey. Antibiotic susceptibility testing was performed using the disk diffusion method for ceftazidime\u2013avibactam and broth microdilution for both colistin and ceftazidime\u2013avibactam. Molecular detection of carbapenemase genes was carried out using polymerase chain reaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Ceftazidime\u2013avibactam resistance was identified in 21.5% (67\/312) of CRKp isolates. Among these isolates, 37.3% harbored both OXA-48 and NDM genes, 13.4% carried NDM alone, 10.4% carried OXA-48 alone, and 38.8% lacked these genes. The majority of resistant isolates originated from urine (31.3%), followed by tracheal aspirate (29.9%), and blood (22.4%) specimens. The prevalence of colistin susceptibility among ceftazidime\u2013avibactam-resistant CRKp isolates was 56.7%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The coexistence of NDM and OXA-48 genes is a major contributor to ceftazidime\u2013avibactam resistance in CRKp isolates, particularly in urinary and respiratory tract infections. These findings underscore the need for ongoing surveillance and tailored antibiotic stewardship programs to control the spread of resistance in hospital settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045289","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:02:47Z","timestamp":1760331767000},"page":"e45289","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of carbapenemase genes and antibiotic resistance profiles in ceftazidime\u2013avibactam resistant Klebsiella pneumoniae isolates: A single-center cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-6415","authenticated-orcid":false,"given":"Ipek","family":"Ko\u00e7er","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Sanko University, Gaziantep, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-8201","authenticated-orcid":false,"given":"Hadiye","family":"Demirbakan","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Sanko University, Gaziantep, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260113","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"R2-20260113","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups.","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"e02243-16","DOI":"10.1128\/AAC.02243-16","article-title":"Can ceftazidime-avibactam and aztreonam overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in enterobacteriaceae?","volume":"61","author":"Marshall","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-20260113","first-page":"141","article-title":"Epidemiology and genetic traits of carbapenemase-producing enterobacterales: a global threat to human health.","volume":"14","author":"Alvisi","year":"2025","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/bj2760269","article-title":"A standard numbering scheme for the class A beta-lactamases.","volume":"276","author":"Ambler","year":"1991","journal-title":"Biochem J"},{"key":"R6-20260113","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/AAC.01672-07","article-title":"Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.","volume":"52","author":"Carr\u00ebr","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10096-017-3112-7","article-title":"OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.","volume":"37","author":"Mairi","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1060028018790573","article-title":"Critical review of double-carbapenem therapy for the treatment of carbapenemase-producing Klebsiella pneumoniae.","volume":"53","author":"Mashni","year":"2019","journal-title":"Ann Pharmacother"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/antibiotics13070598","article-title":"Ceftazidime-avibactam use in a case series of difficult-to-treat or recurrent infections in pediatric patients with complex chronic conditions: effectiveness and absence of resistance development.","volume":"13","author":"Garc\u00eda-Boyano","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The surgical infection society revised guidelines on the management of intra-abdominal infection.","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"R12-20260113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13017-017-0141-6","article-title":"The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"R14-20260113","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5578\/mb.20229803","article-title":"[In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].","volume":"56","author":"Ho\u015fbul","year":"2022","journal-title":"Mikrobiyol Bul"},{"key":"R15-20260113","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","article-title":"Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.","volume":"4","author":"David","year":"2019","journal-title":"Nat Microbiol"},{"key":"R16-20260113","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of Carbapenemase-producing Enterobacteriaceae.","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R17-20260113","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/AAC.02286-15","article-title":"Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC \u03b2-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.","volume":"60","author":"Karlowsky","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-20260113","doi-asserted-by":"crossref","first-page":"124.e1","DOI":"10.1016\/j.cmi.2019.08.020","article-title":"Emergence of ceftazidime\/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R19-20260113","doi-asserted-by":"crossref","first-page":"100603","DOI":"10.1016\/j.ijmmb.2024.100603","article-title":"Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: a phenotypic and genotypic analysis.","volume":"49","author":"Krithika","year":"2024","journal-title":"Indian J Med Microbiol"},{"key":"R20-20260113","first-page":"3427972","article-title":"Retrospective tertiary care-based cohort study on clinical characteristics and outcomes of ceftazidime-avibactam-resistant carbapenem-resistant klebsiella pneumoniae infections.","volume":"2024","author":"Ahmed","year":"2024","journal-title":"Crit Care Res Pract"},{"key":"R21-20260113","doi-asserted-by":"crossref","first-page":"10.7754\/Clin.Lab.2022.220827","DOI":"10.7754\/Clin.Lab.2022.220827","article-title":"In vitro activity of cefiderocol and ceftazidime-avibactam, against carbapenemase-producing enterobacterales.","volume":"69","author":"Ozyurt","year":"2023","journal-title":"Clin Lab"},{"key":"R22-20260113","first-page":"256","article-title":"Ceftazidime \u2013 avibactam susceptibility among carbapenem-resistant enterobacterales in a pilot study in Turkey.","volume":"68","author":"Ozger","year":"2021","journal-title":"Acta Microbiol Immunol Hung"},{"key":"R23-20260113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5578\/mb.20124","article-title":"[The epidemiology of carbapenemases in escherichia coli and klebsiella pneumoniae isolated in 2019 in Turkey].","volume":"55","author":"S\u00fcz\u00fck Yildiz","year":"2021","journal-title":"Mikrobiyol Bul"},{"key":"R24-20260113","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14787210.2022.2128764","article-title":"Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections.","volume":"20","author":"Isler","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R25-20260113","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1038\/s41598-024-67347-5","article-title":"Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae.","volume":"14","author":"T\u00fczemen","year":"2024","journal-title":"Sci Rep"},{"key":"R26-20260113","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-0691.2012.03823.x","article-title":"Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria.","volume":"18","author":"Akova","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R27-20260113","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2217\/fmb-2020-0012","article-title":"Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing enterobacterales.","volume":"15","author":"Dietl","year":"2020","journal-title":"Future Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:03:04Z","timestamp":1768334584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":26,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045289","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"2024-12-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}